Topical Drug Delivery Market to Reach US$ 117 Bn by 2025

Published | October 2019

According to BlueWeave Consulting, The Global Topical Drug Delivery Market anticipated to reach US$ 117 billion by 2025 with a significant CAGR of 5.4%. The increasing rate of skin and eye disease prevalence is becoming one of the factors to drive growth in the global topical drug delivery market. The rising trend of skin-related diseases such as psoriasis, cancer, etc. due to changing lifestyle patterns is contributing to an increase in the demand for topical drug delivery in the market with a significant growth rate. Rising alternative modes of drug delivery such as injectable, oral, and pulmonary of the drug delivery care sector are anticipated to hamper the growth of topical drug delivery market in the upcoming years.

Growing prevalence of diabetes expected to dominate the global topical drug delivery market

The increasing rate of disposable income, preference shifts in eating habits are the key factor contributing to diabetes prevalence. The rising rate of diabetes prevalence is the key factor anticipated to drive the growth and demand of topical drug delivery system in the market with eye care segmentation. Semi-solid formulation segment is expected to dominate the global topical drug delivery market due to an advantage factor such as easy drug release, patient acceptability, and multiple applications in the upcoming years with the commendable growth rate.

Technological advancement in the homecare setting is the key factor propelling the growth in the market in the forecast period

Technological advancement in the healthcare sector, coupled with increasing healthcare expenditure anticipated to dominate the global market in the upcoming years. Properties such as deep penetration of drugs within the body, preference shift of patient due to non-invasive nature and increasing rate of geriatric population, R&D, biologics delivery via a transdermal route with small player’s acquisition expected to drive the global topical drug delivery market in the upcoming years with a significant growth rate. The market is anticipated to dominate by homecare setting as a homecare setting to eliminate the hospital visit to save patient time and money. The rising affordability and convenience are the key factor expected to propel the growth during the forecast period of 2019-2025.

Topical Drug Delivery Market: competitive landscape

Some of the major industry players are Glaxosmithkline, Janssen Global Services (A Subsidiary of Johnson & Johnson), Bausch Health Companies, Merck & Co., Bayer AG, Hisamitsu Pharmaceutical, Nestlé Sa, Novartis AG, Glenmark Pharmaceuticals, Cipla and Other Prominent Player.

Browse Detailed Analysis with TOC, “Global Topical Drug Delivery Market by Type (Semisolids (Creams, Ointments, Gels, Lotions), Liquids, Solids, Transdermal Products), Route (Dermal, Ophthalmic, Rectal, Vaginal, Nasal), Facility of Use (Homecare, Hospital, Burn Center), By Region (North America, Europe, Asia Pacific, Middle East & Africa and Latin America); Trend Analysis, Competitive Market Share & Forecast, 2015-2025”

At https://www.blueweaveconsulting.com/global-topical-drug-delivery-market-bwc19313

The in-depth analysis of the report provides the growth potential, upcoming trends and statistics of nutraceutical products market size & forecast. The report promises to provide state-of-the-art technology of Topical Drug Delivery Market and industry insights which help decision makers to take sound strategic decisions. Furthermore, the report also analyzes the market drivers and challenges and competitive analysis of the market.